Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients

Celltrion has begun recruiting mild Covid-19 patients for the Phase 1 clinical trial of its antibody therapy, CT-P59, after obtaining approval for an …

Source: Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients